Diastolic cardiac failure: Therapeutic modalities;Insuffisance cardiaque diastolique: Modalites therapeutiques

Archives des Maladies du Coeur et des Vaisseaux

Volumn 91, Issue 11, 1998, Pages 1365-1369

  Millaire, A ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANGINA PECTORIS AGENT; ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRIC ACID DERIVATIVE; VERAPAMIL;

AORTA VALVE STENOSIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVERSION; CORONARY ARTERY DISEASE; DIASTOLE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART RATE; HEART VENTRICLE FILLING; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; CONGESTIVE HEART FAILURE; DECISION MAKING; DRUG EFFECT; DRUG THERAPY; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; PATIENT CARE PLANNING;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-ARRHYTHMIA AGENTS; DECISION MAKING; DIASTOLE; DRUG THERAPY; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; PATIENT CARE PLANNING; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 0031772311     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Stauffer JC, Gaasch WH. Recognition and treatment of left ventricular diastolic dysfunction. Prog Cardiovasc Dis 1990 ; 32 : 319-32.
2. Topol EJ, Traill TA, Fortuin NJ. Hypertensive hypertrophic cardiomyoparthy of the elderly. N Engl J Med 1985 ; 312 : 277-83.
3. Smith ER, Smiseth OA, Kingma I, Manyari D, Belenkie I, Tyberg JV. Mechanism of action of nitrates. Role of changes in venous capacitance and in the left ventricular diastolic pressure-volume relation. Am J Med 1984 ; 76 : 14-21.
4. Cohn JN, Johnson G, and Veterans Administration Cooperative Study Group. Heart failure with normal ejection fraction. The V-HeFT Study. Circulation 1990 ; 81(suppl III):III-48-III-53.
5. Bonow RO, Dilsizian V, Rosing DR, Moron BJ, Bacharach SL, Green MV. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy : short and long-term effects. Circulation 1985 ; 73 : 853-64.
6. Setaro J, Zaret BL, Schulman DS, Black HR, Soufer R. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic performance. Am J Cardiol 1990 ; 66: 981-6.
7. Brutsaert DL, Sys SU, Gillebert TC. Diastolic failure : pathophysiology and therapeutic implications. J Am Coll Cardiol 1993 ; 22 : 318-25.
8. The Task Force of the Working Group on Heart Failure of the European Society of Cardiology. The treatment of heart failure. Eur Heart J 1997 ; 18 : 736-53.
9. Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology / American Heart Association Task force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). J Am Coll Cardiol 1995 ; 26 : 1376-98.
10. Lorell BH, Isoyama S, Grice WN, Weinberg EO, Apstein CS. Effects of ouabain and isoproterenol on left ventricular diastolic function during low-flow ischemia in isolated, blood-perfused rabbit hearts. Circ Res 1988 ; 63 : 457-67.
11. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997 ; 336 : 525-33.
12. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium fibrosis and renin-angiotensin-aldosterone system. Circulation 1991 ; 83 : 1849-65.
13. Brilla CG, Janicki JS, Weber KT. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991 ; 83 : 1771-9.
14. Brilla CO, Matsubara LS, Weber KT. Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. Am J Cardiol 1993 ; 71 : A12-A16.
15. Carroll JD Lang RM, Neumann AL, Borow KM, Rajfer SI. The differential effects of positive inotropic and vasodilator therapy on diastolic properties in patients with congestive cardiomyopathy. Circulation 1986 ; 74 : 815-25.
16. Monrad ES, McKay RG, Baim DS et al. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone. Circulation 1984 ; 70 : 1030-7.
17. Millaire A. Traitement de l'insuffisance cardiaque chronique par les nouveaux inotropes. In : Komajda M. Insuffisance cardiaque, du diagnostic au traitement. Paris : PIL, 1998 : 100-6.
18. Bonow RO, Frederick TM, Bacharach SL et al. Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil. Am J Cardiol 1983 ; 51 : 1386-91.
19. Paulus WJ, Lorell BH, Craig WE, Wynne J, Murgo JP, Grossman W. Comparison of the effects of nitroprusside and nifedipine on diastolic properties in patients with hypertrophic cardiomyopathy: altered left ventricular loading or improved muscle inactivation ́ J Am Coll Cardiol 1983 ; 5 : 879-86.
20. Gilligan DM, Chan WL, Joshi J et al. A double-blind, placebo-controlled crossover trial of nadolol and verapamil in mild and moderately symptomatic hypertrophic cardiomyopathy. J Am Coll Cardiol 1993 ; 21 : 1672-9.
21. Nishimura RA, Schwartz RS, Holmes DR Jr, Tajik AJ. Failure of calcium channel blockers to improve ventricular relaxation in humans. J Am Coll Cardiol 1993 ; 21 : 182-8.
22. Ammar A, Wong M, Singh BN. Divergent effects of chronic amiodarone administration on systolic and diastolic function in patients with heart disease. Am J Cardiol 1995 ; 75 : 465-9.
23. Dahlöf B, Pennert K, Hansson L Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 1992 ; 5 : 95-110.
24. Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA 1996 ; 275 : 1507-13.
25. Bonow RO, Leon MB, Rosing DR et al. Effects of verapamil and propranolol on left ventricular systolic function and diastolic filling in patients with coronary artery disease : radionuclide angiographic studies at rest and during exercise. Circulation 1982 ; 65 : 1337-50.
26. Lorell BH, Turi Z, Grossman W. Modification of left ventricular response to pacing tachycardia in nifedipine in patients with coronary artery disease. Am J Med 1981 ; 71 : 667-75.
27. Rodrigues EA, Lahiri A, Raftery EB. Improvement in left ventricular diastolic function in patients with stable angina after chronic treatment with verapamil and nicardipine. Eur Heart J 1987 ; 8 : 624-9.
28. Mizuno K, Arakawa K, Shibuya T et al. Improved regional and global diastolic performance in patients with coronary artery disease after percutaneous transluminal coronary angioplasty. Am Heart J 1988 ; 115: 302-6.
29. Lawson WE, Seifert F, Anagnostopoulos C, Hills DJ, Swinford RD, Cohn PF. Effect of coronary artery bypass grafting on left ventricular diastolic function. Am J Cardiol 1988 ; 61 : 283-7.
30. Humphrey LS, Topol EJ, Rosenfeld GI et al. Immediate enhancement of left ventricular relaxation by coronary artery bypass grafting: intraoperative assessment. Circulation 1988 ; 77 : 886-96.
31. Adelman AG, Shah PM, Gramiak R, Wigle ED. Long-term propranolol therapy in muscular subaortic stenosis. Br Heart J 1970 ; 32 : 804-11.
32. Rosing DR, Condit JR, Maron BJ et al. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration. Am J Cardiol 1981 ; 48 : 545-53.
33. Matsubara H, Nakatani S, Nagata S et al. Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1995 ; 26 : 768-75.
34. Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994 ; 90 : 2731-42.
35. Cohn LH, Trehan H, Collins JJ Jr. Long-term follow-up of patients undergoing myotomy/myectomy for obstructive hypertrophic cardiomyopathy. Am J Cardiol 1992 ; 70 : 657-60.
36. Millaire A. Le traitement chirurgical des cardiomyopathies hypertrophiques ; techniques, indications et résultats. Arch Mal Cæur 1995 ; 88(suppl 4) : 585-8.
37. Villari B, Vassalli G, Monrad ES, Chiariello M, Turina M, Hess OM. Normalization of diastolic dysfunction in aortic stenosis late after valve replacement. Circulation 1995 ; 91 : 2353-8.
38. Friedrich SP, Lorell BH, Rousseau MF et al. Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis. Circulation 1994 ; 90 : 2761-71.